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Abstract
The transcriptome, as the pool of all transcribed elements in a given cell, is regulated by the interaction between different
molecular levels, involving epigenetic, transcriptional, and post-transcriptional mechanisms. However, many previous
studies investigated each of these levels individually, and little is known about their interdependency. We present a systems
biology study integrating mRNA profiles with DNA–binding events of key cardiac transcription factors (Gata4, Mef2a,
Nkx2.5, and Srf), activating histone modifications (H3ac, H4ac, H3K4me2, and H3K4me3), and microRNA profiles obtained in
wild-type and RNAi–mediated knockdown. Finally, we confirmed conclusions primarily obtained in cardiomyocyte cell
culture in a time-course of cardiac maturation in mouse around birth. We provide insights into the combinatorial regulation
by cardiac transcription factors and show that they can partially compensate each other’s function. Genes regulated by
multiple transcription factors are less likely differentially expressed in RNAi knockdown of one respective factor. In addition
to the analysis of the individual transcription factors, we found that histone 3 acetylation correlates with Srf- and Gata4-
dependent gene expression and is complementarily reduced in cardiac Srf knockdown. Further, we found that altered
microRNA expression in Srf knockdown potentially explains up to 45% of indirect mRNA targets. Considering all three levels
of regulation, we present an Srf-centered transcription network providing on a single-gene level insights into the regulatory
circuits establishing respective mRNA profiles. In summary, we show the combinatorial contribution of four DNA–binding
transcription factors in regulating the cardiac transcriptome and provide evidence that histone modifications and
microRNAs modulate their functional consequence. This opens a new perspective to understand heart development and
the complexity cardiovascular disorders.
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Introduction
It is long known that an evolutionary conserved orchestra of
transcription factors controls cardiac development and function.
More recently the contribution of epigenetic and post-transcrip-
tional mechanisms has been identified. Many successful studies
have focused on these different aspects independently, but it is still
an open question, how these molecular regulatory mechanisms
interact. The ability of transcription factor binding to DNA is
highly influenced by the chromatin status and epigenetic
mechanisms play an important role in establishing and maintain-
ing transcriptional programs. This layer of control comprises
posttranslational modification of histones, DNA methylation and
chromatin remodeling. To understand networks directing gene
expression, the interplay between different transcription and
epigenetic factors has to be considered. Furthermore, recent
studies have started to unveil powerful roles for microRNAs
(miRNAs) in regulating and fine-tuning mRNA profiles via either
translational repression or mRNA degradation. It should be noted
that gene expression profiles as obtained by standard microarrays
or next-generation sequencing reflect mRNA profiles, which
depend on the gene transcription as well as the decay of mRNA.
In line with this, we present a study integrating mRNA profiles
with transcription factor-DNA interaction data, histone modifica-
tion marks and posttranscriptional regulation by miRNAs.
The DNA-binding transcription factors Gata4, Mef2a, Nkx2.5
and Srf play pivotal roles for the differentiation, maturation and
homeostasis of cardiomyocytes. Mice lacking Gata4 die at E8.5
with failure of ventral morphogenesis and heart tube formation
[1,2]. Targeted disruption of Nkx2.5 leads to abnormal heart
morphogenesis with lethality at E9.5 [3]. Mef2a knockout mice die
within the first postnatal week and exhibit myofibril fragmentation
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and impaired myocyte differentiation [4]. Srf-null mice show severe
defects in the contractile apparatus of cardiomyocytes and die at
the gastrulation stage [5,6]. However, Gata4, Mef2a, Nkx2.5 and
Srf not only display independently a central role for cardiac
development and function, they also regulate each other’s
expression [7–10]. Despite their impact, we still have limited
understanding of the global cardiac transcription networks driven
by these factors in a direct and indirect manner.
Moreover, we lack knowledge to which extent epigenetic marks
such as histone modifications interfere with the regulation of
downstream targets. The N-terminal histone tails serve as targets
for a variety of reversible posttranslational modifications including
acetylations or methylations. Both have a main impact on
chromatin structure and represent binding sites for transcriptional
regulators [11–13], thus promoting or inhibiting transcription.
They are put in place by specific enzyme families and are removed
by others [14,15]. Hence histone acetylation is a dynamic process
and for instance, mice lacking histone deacetylases 5 and 9
(HDAC5 and 9) show cardiac defects typical for abnormalities in
growth and maturation of cardiomyocytes [16]. A superactivation
of Mef2 based on its interaction with HDACs is proposed [17].
However, our understanding of the underlying molecular
mechanisms is still premature.
It was reported that only 5–15% of differentially expressed
genes in short interference RNA (siRNA) knockdown experiments
are also direct transcription factor targets identified by chromatin
immunoprecipitation (ChIP) and vice versa [18–23]. There is
considerable evidence, that cascades of transcriptional regulators
form networks. Loss of one factor will directly affect a few genes,
but among those genes are other transcriptional regulators whose
function is now altered, affecting a further set of downstream
genes. In addition, it has to be considered that a significant
proportion of downstream effects mediated by DNA-binding
transcription factors is promoted via downstream miRNAs or
other regulators. For example Srf regulates the transcription of
miRNAs such as the smooth muscle relevant miR-143 and miR-
145 [24]. Feedback loops between Srf/Mef2 and muscle-specific
miR-133/miR-1 have been described, and both miRNAs are
expressed throughout heart development and play important roles
in muscle proliferation and differentiation [25–28]. Furthermore,
miR-1 promotes myogenesis by targeting HDAC4 [26], a
transcriptional repressor of muscle gene expression, and thus
represents an interface to histone acetylation.
Taken the above, we investigated the transcription network
driven by Gata4, Mef2a, Nkx2.5 and Srf in cardiomyocytes in a
genome-wide approach. First, we focused on the direct down-
stream targets by evaluating in-vivo DNA-binding sites of the
respective factors and correlated these binding events with the
expression level of related genes. Second, we investigated the
functional consequence of the proposed regulation in knockdown
experiments and built respective transcription networks. Third, we
analyzed if co-occurrence with activating histone modifications
could impact on gene expression levels of direct targets. Fourth, we
studied the modulation of mRNA levels by miRNA alterations
seen in knockdown experiments. Finally, we integrated the three
levels regulating mRNA profiles and generated a comprehensive
transcription network centered on Srf. Based on our analysis we
argue that transcription networks have a comparable dependency
on transcription factor binding, modulation by histone modifica-
tions as well as regulation by miRNAs. In addition to the global
perspective, our networks provide distinct information on the
regulation of individual genes especially with regard to cardiac
function.
Results
We used the cardiomyocyte cell line HL-1 to study the global
transcription network driven by the DNA-binding transcription
factors Gata4, Mef2a, Nkx2.5 and Srf. The mRNA as well as
miRNA expression profiles of beating HL-1 cells are highly
comparable to the one observed in mouse hearts at P0.5 (Pearson
correlation coefficient of 0.95, Figure 1A left) and human right
ventricle (Pearson correlation coefficient of 0.90, Figure 1A right;
data unpublished). The use of a cell line enabled us to cope with
the technical limitations of our different approaches (ChIP-chip/
seq, miRNA-seq, siRNA knockdown, microarrays) and supported
a single cell-type specific study. We validated the key findings in a
time-course of mouse hearts during the cardiac adaptation and
maturation period around birth at E18.5, P0.5 and P4.5.
Cardiac Transcription Regulated by Gata4, Mef2a, Nkx2.5,
and Srf
We developed a custom two-array set (26385K) with Nimble-
Gen using a tilling approach for promoter and enhancer regions
(10kb upstream), and first exon and intron sequences of 12,625
transcripts (65% of all RefSeq promoters). This enabled the
analysis of sequence regions beyond standard promoter arrays. We
selected 89Mbp of the mouse genome related to transcripts of 13
data sources (Table S1), which included all known expressed
skeletal, smooth and cardiac muscle genes in human and mouse.
Using ChIP-chip analyses we identified several hundreds of
transcription factor binding sites (TFBS) for Gata4 (447), Mef2a
(999), Nkx2.5 (383) and Srf (1,335) in mouse HL-1 cardiomyo-
cytes, which were related to 345 Gata4, 701 Mef2a, 276 Nkx2.5
and 1,150 Srf target genes (Table S15). Figure 1B shows the
distribution of observed binding sites relative to the transcriptional
start site (TSS). An average of 24% of TFBS were localized in
potential enhancer regions with a distance between 2.5kb to 10kb
upstream from any transcriptional start site.
Author Summary
An evolutionary conserved orchestra of transcription
factors controls cardiac development and function. More
recently the contributions of epigenetic and post-tran-
scriptional mechanisms like histone modifications and
microRNAs have been identified. The interplay between
these regulatory mechanisms is still an open question.
However, perturbations of the cardiac transcriptome,
triggered by all three levels of regulation, are underlying
cardiovascular disease such as congenital heart malforma-
tions. Here, we show the impact of the interdependencies
of four key transcription factors (Gata4, Mef2a, Nkx2.5, and
Srf) and the contribution of activating histone modifica-
tions and microRNAs on the cardiac transcriptome. We
found that even these non-paralogous transcription
factors can partially compensate each other’s function.
Our data show that histone 3 acetylation correlates with
Srf- and Gata4- dependent gene activation. Moreover, we
predict a large proportion of indirect Srf targets to be
regulated by Srf-dependent microRNAs, which thus might
represent an important intermediate layer of regulation.
Taken together, we suggest that the different levels
regulating cardiac mRNA profiles have a high degree of
interdependency and the potential to buffer each other,
which presents a starting point to understand the
phenotypic variability typically seen in complex cardiovas-
cular disorders.
Transcription Factor, Histone Acetylation, miRNA
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The respective target genes of the studied transcription factors
included 42 known targets (Table S2), substantiating the reliability
of the system. In addition, we found several genes previously
shown to be deregulated in mutants as direct targets of the
respective transcription factor. For example, Gata4 and Nkx2.5
levels are decreased in cells depleted of Mef2 [8] and both genes
show binding of Mef2a at their promoters in our data.
To gain further insights into the transcription factor function-
ality, we investigated which Gene Ontology (GO) terms were
significantly overrepresented among target genes of each factor
when compared to all genes represented on the array. The
significant GO terms (p,0.001) show a stronger than expected
association with heart development and function and are highly
related to the phenotypes reported for the respective transcription
factor (Tables S3, S4, S5, S6). For example, the GO terms ‘muscle
cell differentiation’ and ‘heart looping’ are significantly overrep-
resented among Mef2a and Nkx2.5 targets, respectively, and both
are key features of corresponding knockout mouse models [3,4].
We investigated the sequences underlying the transcription
factor binding sites in more detail and searched for TRANSFAC
[29] motifs within the presumably bound sequences. The
TRANSFAC matrices used for motif search are listed in Table
S7. For Gata4, Nkx2.5 and Mef2a 84–94% of all ChIP binding
events harbored respective binding motifs. For Srf, the fraction of
ChIP binding events with predicted motifs was very small (169 out
of 1,335 binding sites). However, Srf is well-known to bind the
CArG-box CC(A/T)6GG [30], which is only partially represented
by TRANSFAC motifs. Using a pattern matching approach we
found the CArG-box in 1,063 (approximately 80%) Srf binding
events. Furthermore, more than every second binding event of the
studied factors occurred at sequence sites containing at least two
times the respective transcription factor motif or pattern.
Figure 1. Binding site location and co-occurrence of Gata4, Mef2a, Nkx2.5, and Srf. HL-1 mRNA and miRNA expression profiles are highly
comparable to the ones observed in human and mouse hearts. (left) Gene expression levels obtained from HL-1 cells and P0.5 of C57/BL6 mouse
heart. (right) Rank-transformed miRNA expression levels in HL-1 cells and human right ventricle. (B) Positional distribution of transcription factor
binding sites relative to the transcription start site (TSS). The y-axis shows the number of transcription factor binding sites per transcription factor as
bar plots in 2.5kb windows. Most binding sites (,75%) are located within close proximity to the TSS. (C) Gata4, Mef2a, Nkx2.5 and Srf frequently bind
together. Shown is the combinatorial binding of all four transcription factors to 498 common target genes. 91 target genes were bound by all four
factors (black), 121 target genes were bound by three (dark gray) and 286 target genes were bound by two transcription factors (gray). The total
number of genes solely bound by a single TF are indicated above the respective TF. (D) Odds ratios of pair-wise contingency tables of the occurrence
of transcription factor binding sites at one gene. Total numbers of pair-wise occurrences are given. The numbers in white boxes represent the total
number of bound genes for the respective transcription factor. Red indicates positive, blue negative correlation. Gata4 and Nkx2.5 had the lowest
number of targets (345 for Gata4, 276 for Nkx2.5) but we observed co-binding to 143 genes and their occurrence is therefore highly correlated.
Although Mef2a and Srf bind at 320 genes together, they each have a much higher number of target genes.
doi:10.1371/journal.pgen.1001313.g001
Transcription Factor, Histone Acetylation, miRNA
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We studied the cross-species conservation of binding motifs and
found in ,10% complete sequence conservation between human
and mouse. In 27% the binding sites were localized in regions
conserved across 18 vertebrate species based on PhastCons
elements [31]. Thus, by focusing only on conserved sequence
regions a priori more than two-third of the binding sites would be
missed.
Combinatorial Regulation by Multiple Transcription
Factors
The investigated transcription factors are known to co-regulate
targets and pairwise physical interaction has been described
between several of these factors [32,33]. Nevertheless, it is
unknown how frequently this co-binding occurs in-vivo. Conse-
quently, we investigated the assignment of Gata4, Nkx2.5, Mef2a
and Srf to the same gene. We observed frequent co-regulation by
more than one transcription factor, where Gata4 and Nkx2.5
shared 143 targets (41% and 52%, respectively) and Mef2a and Srf
shared 320 target genes (46% and 28%, respectively) (Figure 1C
and 1D). For 91 genes co-binding of all four transcription factors
was observed and in 85 cases the binding was observed at close
proximity within a 500bp window. These data underline the
complexity and cooperative regulation of gene regulation shown in
our model of four DNA-binding transcription factors.
Functional Consequences of Transcription Factor Binding
We investigated whether the transcription factors act mainly as
activators or repressors in a wildtype situation. We carried out
genome-wide expression array analysis of the contracting HL-1
cardiomyocytes and classified all transcripts as expressed or non-
expressed. We found that for each of the four transcription factors
approximately 80% of the target genes were expressed and their
expression levels were significantly enhanced compared to non-
targets (p,0.005).
Considering the cooperative co-binding of the investigated
transcription factors, we were interested in the functional
consequence of significantly reducing the quantity of each of the
factors. Therefore, we used siRNA technique to reduce the protein
levels of investigated transcription factors by more than 70% and
studied its consequence for gene transcription. The reduction at
mRNA and protein level was monitored by quantitative PCR and
Western Blot analysis (Figure S1 and Figure 2A) and the genome-
wide effects on transcript levels were measured by expression array
analysis (Table S17). All data were based on a total of 4 replicate
experiments using duplicates of two different siRNAs per
transcription factor. The majority of deregulated transcripts were
downregulated in the siRNA treated samples, confirming a
primarily activating function of the transcription factors. Perform-
ing Annexin assays and Tryptophan Blue staining, we observed an
Figure 2. RNAi–induced knockdown of Gata4, Mef2a, Nkx2.5, and Srf. (A) Knockdown efficiency of Gata4, Mef2a, Nkx2.5 and Srf in HL-1 cells
using two different siRNAs was analyzed on protein level by Western Blot 48h after transfection. Histone 3 (H3) served as loading control. In
independent experiments similar knockdown efficiencies were obtained. (B) Odds ratios of pair-wise contingency tables of differentially expressed
transcripts after RNAi knockdown of the respective transcription factor. Total numbers of pair-wise occurrences are given. The numbers in white
boxes represent the total number of deregulated transcripts. Red indicates positive, blue negative correlation. Mef2a shows the lowest number of
differentially expressed transcripts (119) probably due to buffering effects of the other Mef2 family members. Despite this fact, Mef2a shares a high
number of deregulated transcripts with the other transcription factors. Of note, transcription factors having a high number of common binding
targets (see Figure 1D) share only a small number of co-regulated genes in RNAi knockdown. (C) Transcription factor network showing a selection of
cardiac relevant genes bound in ChIP-chip and/or ChIP-seq, and significantly differentially expressed in RNAi knockdown experiments of the
respective factor. Up- and downregulation of genes is depicted and occurrence of ChIP binding marked by color-coded circles.
doi:10.1371/journal.pgen.1001313.g002
Transcription Factor, Histone Acetylation, miRNA
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increased apoptosis and cell death in particular when Gata4 or Srf
were knocked down (Figure S2), which is in line with previous data
[34–36].
Analogous to our analyses of common downstream targets based
on transcription factor binding events, we studied common
differentially expressed genes. The different factors share a compa-
rable proportion of differentially expressed genes when knocked down
(Figure 2B). An opposing effect for targets regulated by several
transcription factors was only observed in two cases:Myocd and Tpm1.
Figure 2C shows the combinatorial regulation of a selection of heart
and muscle relevant, directly bound and differentially expressed
genes. This includes genes coding for structural proteins like Actc1,
Actn2, Tnnt2, Mybpc3 or Myh6; growth factors like Igf1 or apoptosis
factors like Casp3. The transcription factor Tbx20 represents an
example for a gene that is bound and regulated by all four factors. A
broad panel of differentially expressed genes was further confirmed by
quantitative real-time PCR (Table S8).
Finally, we compared the differentially expressed genes in
siRNA knockdown experiments to the direct target genes
identified by ChIP. Analyzing the overlap focusing on the
functional role of the respective genes, we found that both datasets
share the Gene Ontology terms reflecting heart and muscle
development and function. For example, muscle cell differentia-
tion, muscle contraction and heart development are the main
functional roles for direct targets of Srf as well as the respective
differentially expressed genes. However, only a small fraction of
direct target genes (,10%) was also differentially expressed,
pointing to the combinatorial nature of gene regulation. In
accordance, we found that genes bound by multiple transcription
factors were significantly less likely differentially expressed (x2-test
p,0.001). Likewise transcription factors having a high number of
common binding targets share only a small number of co-
regulated genes in RNAi knockdown (correlation shown in
Figure 2B is inverse to the correlation in Figure 1D). In addition,
binding in a poised state or buffering by epigenetic mechanisms
such as histone modifications which interfere with the accessibility
of the DNA should be considered. It has to be kept in mind that
transcription factor binding depends on binding affinity and
accessibility of binding sites. The regulatory potential of several
factors has been reported to be strongly dosage dependent (e.g.
Tbx5 [37] and Gata4 [38]). Furthermore, a significant proportion
of differentially expressed genes in RNAi are likely to be regulated
in an indirect manner. Recent studies show the powerful roles for
miRNAs in controlling mRNA profiles largely by silencing target
genes, via either translational repression or mRNA degradation.
Histone 3 Acetylation Correlates with the Activating
Potential of Transcription Factors
To explore the influence of histone modifications as an
epigenetic mechanism to modulate gene expression, we analyzed
our transcription factor binding data in the context of co-occurring
histone marks. In a previous study we investigated the localization
of four histone modifications, which are known to promote an
open chromatin state (H3K9K14ac, H4K5K8K12K16ac,
H3K4me2 and H3K4me3) [39]. We found that ,80% of the
respective transcription factor binding events are marked by one
or more of these histone modifications, whereas in a randomized
simulation only 23% are expected to co-occur (Figure S3). We
consequently investigated whether the presence of any of these
marks correlates with higher expression levels of direct target genes
and found a significant impact for histone 3 acetylation (H3ac)
only (Figure 3A and Figure S4). For Nkx2.5 and Mef2a the
expression levels of direct targets were significantly higher than the
reference group, independent of whether H3ac was present or not.
Genes showing neither transcription factor binding nor H3ac were
used as a reference. In case of Gata4 and Srf the expression levels
of direct targets were only significantly increased when binding
sites were additionally marked by H3ac. The enhanced expression
levels depending on H3ac co-occurrence is further depicted in
Figure 3B, which shows confirmation experiments of nine genes
using quantitative PCR. In conclusion, our data provide evidence
that acetylation of histone 3 supports the activating function of
Gata4 and Srf, which might be mediated via p300. The histone
acetyl transferase p300 not only acetylates lysine residues on
histone 3 but also on Gata4, thereby enhancing the DNA-binding
and activating potential of this transcription factor [40]. The Srf
cofactor Myocardin has been reported to recruit p300 to Srf
binding sites whereby histone 3 acetylation is induced and gene
expression enhanced [41]. Finally, we studied the change of H3ac
marks as a consequence of Srf knockdown using ChIP followed by
qPCR. Strikingly, we found complementary alterations of H3ac in
a panel of relevant promoter regions (Figure 3C and 3D).
Histone 3 Acetylation Correlates with Srf Target Gene
Activation
To validate and further investigate the correlation of H3ac with Srf
target gene expression, we performed genome-wide ChIP-seq
experiments in HL-1 cardiomyocytes (Table S16). We found a
synergistic effect of H3ac and Srf binding when compared to non-
bound genes or genes solely bound by either of both (Figure 3E). The
influence of H3 acetylation marks was further substantiated by RNAi
knockdown of Srf in HL-1 cells (Figure 3F). In accordance to its mainly
activating function, we found a significant decrease in expression levels
of genes bound by Srf. However, this decrease was significantly
reduced in genes additionally marked by H3ac in the wild-type.
In a further attempt to confirm our results gathered in cell
culture, we studied Srf and H3ac binding and their influence on
gene expression in mouse hearts in a time-series during cardiac
maturation at three developmental stages E18.5, P0.5 and P4.5
around birth. From the fetal to the postnatal stage, the heart
adapts to the body circulation and cardiomyocytes mature. During
this process the heart increases in size (Figure 4A), the cells
elongate, myofibrils align and cell-cell contacts become bipolar.
Immunostaining of a-Actinin-1 and Connexin 43 illustrates
hypertrophy of cardiomyocytes, assembly of the sarcomeric z-
discs and development of gap junction [42]. Based on ChIP-chip/
seq results for Srf and H3ac in HL-1 cells, we analyzed promoter
binding regions of genes and miRNAs relevant for this process
using ChIP followed by quantitative real-time PCR. The selection
comprises (Figure 4B): Dmpk (kinase of myogenin), Slmap
(sarcomeric protein), Picalm (clathrin assembly protein), miR-
133a (cardiac and muscle-specific miRNA), the growth factor Igf1
and its receptor Igf1r, Pitx2c (cardiac transcription factor), and Nrp2
(interactor of Vegf). We found a high correlation between the
changes of Srf and H3ac binding and the gene expression levels
over time. In case of Pitx2c and Nrp2 we identified multiple binding
events in HL-1 cells by ChIP-chip/seq of which their functionality
could be confirmed by common changes over time in the mouse
model (Figure 4B). Taken together, these data support an
important role for the co-occurrence of Srf and H3ac in the
regulation of the cardiac maturation process and underline the
influence of histone modifications.
Studying the Impact of miRNAs on the Srf-Driven
Transcription Network
Considering that only a small proportion of differentially
expressed genes in loss-of-function experiments are direct targets
Transcription Factor, Histone Acetylation, miRNA
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Figure 3. Histone 3 acetylation correlates with target gene expression of Srf and Gata4. (A) For each transcription factor the binding sites
were categorized into two groups depending on co-occurrence with histone 3 acetylation (H3ac) in ChIP-chip. Genes marked by Mef2a or Nkx2.5
show significant increased expression levels compared to non-marked genes (Ref) independent of co-occurring H3ac. In contrast, expression levels of
genes bound by Gata4 or Srf were only increased when H3ac marks co-occurred. (B) Confirmation of selected target genes of Srf and Gata4 with H3ac
dependent expression level. HL-1 Illumina expression levels were confirmed using same amount of cDNA for semi-quantitative PCR (30 cycles)
followed by gel electrophoresis and quantitative real-time PCR (40 cycles). Used primer had PCR efficiencies between 1.8–2.0. (C, D) Srf knockdown in
HL-1 cells leads to complementary alterations in H3ac marks at Srf binding sites. H3ac-ChIP enrichments after Srf knockdown (siSrf) compared to
control siRNA (siNon) were measured with qPCR for two groups of promoter regions (H3ac & Srf binding and no H3ac/Srf). The H3ac enrichment was
normalized to Input and IgG controls. Fold changes show significant decrease in H3ac enrichment after Srf knockdown. (E) Confirmation of H3ac
dependent expression of Srf target genes by ChIP-seq. Shown are expression levels of transcripts with H3ac and/or Srf binding close to the
transcriptional start site (TSS,1.5kb). (F) H3ac reduces downregulation of Srf target genes in its knockdown. Shown are fold changes relative to siNon
of downregulated transcripts after Srf knockdown with H3ac and/or Srf binding (TSS,1.5kb). Expression levels (A, E) and fold changes (F) are
represented as box plots. Genes showing neither binding of investigated transcription factors nor H3ac are used as reference. The resulting p-values
are indicated: p,0.001 (***), p,0.01 (**) and p,0.05 (*).
doi:10.1371/journal.pgen.1001313.g003
Transcription Factor, Histone Acetylation, miRNA
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of the respective transcription factors, we were interested in studying
the impact of miRNAs as secondary effectors (Figure 5A, 5B). Again
we focused on the transcription factor Srf, which is known to
regulate cardiac relevant miRNAs like miR-1 and miR-133 [26,43].
We investigated Srf binding using ChIP-seq technology to map Srf
binding sites potentially regulating miRNAs. We found 22 miRNAs
from the miRNA database miRBase with Srf binding within a
region of 10kb. This includes the previously described miR-208 Srf
binding site, as well as other well-known muscle relevant miRNAs
like miR-1, miR-125b, miR-133, miR-143 and miR145 (Table S9).
Second, we performed Srf knockdown using two different siRNAs
and quantified the miRNA expression levels by miRNA-seq (Table
S10 and Table S18). We observed 42 miRNAs (49 loci) to be
differentially expressed in both siRNA experiments, including miR-
208, miR-125b and miR-21. The analysis revealed that most of the
miRNAs were downregulated (78%) supporting the role of Srf as an
miRNA activator (Figure 5A).
To explore the potential effect of the differentially expressed
miRNAs on the Srf network, we assigned confirmed and predicted
targets to each miRNA. We found 192 miRNA targets to be also
differentially expressed in Srf knockdown, with a higher fraction of
upregulated genes (57% of all upregulated genes) compared to
downregulated genes (44% of all downregulated genes, Figure 5A).
The majority of these dysregulated target genes had 39UTR target
sequences for a panel of our differentially expressed miRNAs
(median of 3). The differential expression of miRNAs potentially
impacts up to 45% of all differentially expressed genes by Srf
knockdown, a higher proportion of genes than expected (Fisher’s
exact test, p = 1.77e-5), and provides a feasible explanation for the
observed consequences on the transcriptional portrait (Figure 5B).
A representative example is shown in Figure 5C. It comprises the
three genes Igfbp5 (insulin-like growth factor binding protein 5),
Nfic (nuclear factor I/C) and Ctnnal1 (catenin alpha-like 1). None
of these factors has a direct Srf binding site in ChIP-chip/seq but
all are found to be upregulated in the Srf siRNA knockdown
experiment. Using miRNA target prediction a number of
downregulated miRNAs were found that provide a possible
explanation for this indirect regulation (see Table S11).
Figure 4. The impact of Srf and H3ac on gene expression in mouse hearts during cardiac maturation. (A) Cardiomyocyte maturation
over three developmental stages around birth (E18.5, P0.5 and P4.5) with respect to alignment of myofibrils and cell-cell contacts. Paraffin sections of
mouse hearts double labeled with antibodies against a-Actinin and Connexin 43 (Cx43) and examined under the confocal microscope. The a-Actinin
stained myofibrils (in green, second panel) elongate and assemble throughout the maturation process while Cx43 (in red, third panel) forms distinct
punctuations, which become larger and brighter. Nuclei are visualized in blue by DAPI counterstaining and merged pictures are shown in the lower
panel. Scale bar 10mm. (B) Confirmation of the dependency of expression levels on H3ac and Srf binding in mouse hearts using the time-series E18.5,
P0.5 and P4.5. Expression levels as well as ChIP enrichment were analyzed by quantitative real-time PCR and normalized to Hprt and Input,
respectively. Shown changes of expression levels as well as Srf and H3ac binding over time are in general significant. Values are given in percentages
relative to E18.5. For Pitx2 and Nrp2 the additive effect of several measured genomic regions is shown.
doi:10.1371/journal.pgen.1001313.g004
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Confirmation of Novel Transcription Factor Binding Sites
We confirmed a panel of observed transcription factor binding
sites by qPCR (Figure S5). Using luciferase reporter gene assays,
we validated an Srf binding site in the regulatory region of mouse
miR-125b-1 as well as an Nkx2.5 binding element in the core
promoter region of human DPF3. Mmu-miR-125b-1 is known to
be deregulated in heart diseases [44] and was found to be
differentially expressed in Srf siRNA knockdown. Figure 6A shows
the Srf binding motif and respective Srf ChIP-seq peak within the
regulatory region of miR-125b-1. Luciferase reporter gene assays
with wildtype and mutated fusion constructs confirm its function-
ality. Mutation of the potential Srf binding sequence (CAGC-
CAACRCATAGTAC) significantly reduced the transcriptional
activity of the reporter gene. DPF3 is a novel epigenetic regulator
of heart and skeletal muscle development [13]. Within the 1.2kbp
promoter region we found three Mef2 matrices and one Nkx2.5
matrix using TRANSFAC MATCH [45]. In case of Mef2a, all
three potential binding sites can drive reporter gene expression as
reported [13]. Figure 6B shows the binding of Nkx2.5 to the
human DPF3 core promoter. Subsequently, co-transfection of
reporter construct and increasing amounts of Nkx2.5 expression
vector revealed a dose-dependent transcriptional activation by
Nkx2.5. In line with this, deletion of the potential Nkx2.5 binding
element (TCCACTTTCC) showed that transcriptional activity
was indeed mediated through this motif, as activation was lost in
the mutated construct.
Srf-Centered Transcription Network Integrating
Srf-Binding Events, H3ac, miRNAs, and Differential
Expression in Srf Knockdown
In addition to a genome-wide perspective, our analysis also
provides useful information on the level of individual genes. We
conducted an extensive literature search and built an Srf centered
cardiac transcription network, where we subsequently integrated
our findings from the Srf and histone 3 acetylation ChIP and Srf
siRNA-mediated knockdown experiments (Figure 7). Thus our
data add regulatory content to the nodes, which are connected by
referenced interactions. The network depicts common regulation
by Srf and H3ac as well as the impact of the posttranscriptional
modulation of expression levels by miRNAs. Target genes
important in the cardiovascular context are arranged to their
biological roles like regulation in muscle contractility or cardiac
growth and conduction. As an example the apoptotic machinery is
regulated at all three levels (Srf, H3ac and miRNAs) through
several pathways involving pro-apoptotic (Casp3, miR-320,
Hsp20/a8/a5, Bax) as well as anti-apoptotic (miR-21, Bcl2,
Mcl1) genes.
Discussion
We present a systematic in-vivo analysis of three levels
regulating cardiac mRNA profiles, namely regulation of gene
transcription by epigenetic and genetic factors and posttranscrip-
tional regulation by short noncoding RNAs. We performed
genome-wide profiling of the DNA occupancy of four key cardiac
transcription factors (Gata4, Nkx2.5, Mef2a and Srf) and studied
their co-occurrence with four activating histone modifications
(H3ac, H4ac, H3K4me2 and H3K4me3) as well as the potential
regulatory impact of miRNAs. We combined these data with
mRNA expression profiles in wildtype and RNAi mediated
knockdown cells and finally confirmed key conclusions in a time-
course of cardiac maturation in mouse around birth.
In human and mouse ,2,000 transcription factors, more than
100 different modifications of histone residues and ,700 miRNAs
modulate the mRNA profiles corresponding to ,23,000 genes.
Major insights have been gained into the regulation of the
transcription process by DNA-binding transcription factors [46–
48]. The role of histone modifications in establishing and
maintaining the chromatin status and their function as protein
interaction partners has been discovered [12,13,49]. More
recently, the high impact of miRNAs on mRNA profiles and
their function as inhibitors of the translation process has emerged
[43,50–52]. However, we lack data showing the interaction
between these three levels of regulation. The initial insights were
Figure 5. miRNAs and their impact on the Srf-driven transcription network. (A) RNAi knockdown of Srf in HL-1 cardiomyocytes results in 42
differentially expressed miRNAs (49 loci) (Table S10). Target prediction of these mostly downregulated miRNAs revealed 192 differentially expressed
genes, with a higher fraction of upregulated genes (57% of all upregulated genes) compared to downregulated genes (44% of all downregulated
genes). (B) Direct Srf targets represent only a small fraction of all differentially expressed genes in Srf knockdown (orange and blue). Targets of
differentially expressed miRNAs impact 45% (dark grey) with a partial overlap of direct Srf targets (orange). Approximately 50% of differential
expression is driven by other secondary effects (light grey). (C) Exemplary network of indirect gene regulation by miRNAs. The genes Igfbp5, Nfic and
Ctnnal1, which are not directly bound by Srf, are predicted targets for a set of downregulated miRNAs and are found to be upregulated in the Srf
knockdown.
doi:10.1371/journal.pgen.1001313.g005
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obtained by focusing on the different levels independently, and it
was long thought that transcription factors are the main driving
force. We feel that it is a fine-tuned balance and our data favor a
comparable impact for all three levels with a high degree of
interdependency. Our data indicate that histone 3 acetylation is
involved in the regulation of Srf as well as Gata4 dependent
cardiac genes and moreover potentially compensates the loss of
transcriptional activation in Srf knockdown. Vice versa histone
modifying enzymes represent an important group of direct
downstream targets of Srf (e.g. histone demethylases containing
a Jumonji domain such as Jmjd1c, Jmjd2b, Jmjd3, Jmjd4 and
Jmjd5, see Figure 7). A similar picture emerges for the relationship
of miRNAs and Srf such that the Argonaute proteins Eif2c2
(Ago2) and Eif2c3 (Ago3), which are direct Srf targets, play a key
role for miRNA mediated-mRNA cleavage via the RISC complex
[53]. In line with this, we found a panel of miRNAs deregulated in
Srf knockdown, explaining three times more differentially
expressed genes than Srf binding events alone could do. We are
convinced that these data reflect the high degree of interdepen-
dency between the different levels. In addition, our data underline
the high potency of compensatory regulation between DNA-
binding transcription factors. We show that genes regulated by
multiple transcription factors were significantly less likely differ-
entially expressed in RNAi knockdown of one respective factor. So
far, it had been postulated that members of a gene family (e.g. Mef
transcription factors [4,54,55]) or factors with redundant paralogs
could buffer each others dysfunction [18]. Our data extend these
findings to primarily unrelated transcription factors, which share
common targets.
The observed correlation of histone 3 acetylation with Srf and
Gata4 target gene activation underlines the beneficial effects seen for
HDAC inhibitors for a variety of disease states [17]. Further, we favor
the view that modulation of the histone modification status might be a
plausible explanation for incomplete penetrance or phenotypic
diversity as frequently observed in mouse models with identical
genetic background or in human disease such as congenital heart
disease. Here, a distinct gene mutation can lead to a broad portfolio
of phenotypes, such as mutations in Cited-2 [56,57]. Environmental
factors are potentially causative for these observation and recent
reports show a link between environment and alterations of histone
modifications. Thus, the change of the phosphorylation status and
thereof the activity of histone modifying enzymes mediated for
example via the calcium/calmodulin-dependent protein kinase II
(CaMKII) could represent a mechanistic explanation [58–60].
In accordance with others, we found that the overwhelming
proportion of differentially expressed genes in our RNAi
experiments were indirect targets of the respective transcription
factor. Computational studies suggest that up to 30% of all human
genes are regulated by miRNAs, while each miRNA may control
hundreds of gene targets [61,62]. Our in-vivo data highlight the
global impact of miRNAs on expression profile alterations seen in
transcription factor loss-of-function studies. Differentially ex-
pressed miRNAs in Srf knockdown potentially explain up to
45% of the altered mRNA profile in our study.
Figure 6. Promoter analysis of miR-125b-1 and DPF3. (A) Srf ChIP-seq analysis revealed an Srf binding region downstream of mmu-miR-125b-1.
Shown are the positions of mmu-miR-125b-1 and the Srf binding motif with its core sequence in red. The Srf ChIP-seq peak region was cloned as
mmu-miR-125b-1 promoter into the pGL3basic vector for luciferase reporter gene assay. Srf alone and in combination with its cofactor Myocardin
(Myocd) significantly increases the activation of the luciferase beyond activation driven by endogenous Srf. Mutation of the core sequence
(GCCARTAGT) of the Srf binding motif (Mut) abolished activation by Srf and Myocd compared to the wildtype (WT). (B) ChIP-chip showed binding of
Nkx2.5 to an evolutionary human-mouse conserved region of the DPF3 core promoter. Depicted is the Nkx2.5 binding element, which were deleted
for luciferase reporter gene assays (red). The DPF3 core promoter fused to luciferase alone and in combination with increasing amounts of Nkx2.5
expression vector showed dose-dependent activation by Nkx2.5 beyond the endogenous Nkx2.5 activation. Deletion of the Nkx2.5 binding element
(red) abolished activation by Nkx2.5 compared to the wildtype (WT). The empty pcDNA3.1 expression vector and the empty pGL3basic luciferase
reporter vector served as controls for transcription factors and reporter constructs, respectively. The resulting p-values are indicated: p,0.001 (***),
p,0.01 (**).
doi:10.1371/journal.pgen.1001313.g006
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In summary, our data indicate that the different levels
regulating mRNA profiles have a high degree of interdependency.
The different nodes of the regulatory network have the potential to
modulate each other and should therefore be viewed in context.
Further functional tests will be required to evaluate regulatory
circuits on a single gene basis. It will be of interest to study how the
interdependency of the different factors stabilizes the overall
function of given networks, and how it contributes to the resistance
to external disturbances as well as to the impact of novel
therapeutic tools such as HDAC inhibitors or antagomirs.
Materials and Methods
All methods are abbreviated and additional information is
provided in the online supplement.
Ethics Statement
Human cardiac tissue was obtained from the German Heart
Center with ethical approval by the responsible institutional review
committee (Charite´ 129/2000) and informed consent of patients
[63].
Cell Culture and Cardiac Samples
HL-1 cells were provided by Prof. William C. Claycomb
(Departments of Biochemistry and Molecular Biology and Cell
Biology and Anatomy, Louisiana State University Medical Center,
New Orleans, LA 70112) and cultured as described [64]. The cells
were used for experiments at their maximum contraction.
HEK293T cells were cultivated according to standard protocols.
Mouse hearts at the indicated stages of CD1 and C57/Bl6 strain
were dissected in cold PBS from the rest of the body. For
Figure 7. Srf-centered transcription network integrating Srf binding events, H3ac, miRNAs, and differential expression in Srf
knockdown. The shown transcription network is based on an extensive literature search [7,26,41,43,79–120] and integration of our findings. Our
data add the regulatory content to the nodes, which are connected by referenced interactions. It illustrates the common regulation by Srf and
histone 3 acetylation (H3ac) as well as the impact of the posttranscriptional modulation of expression levels by miRNAs. Data based on Illumina
expression array, ChIP-chip/seq, miRNA-seq and qPCR. Srf binding and H3ac occurrence are depicted in small boxes and up- (red) or downregulation
(green) in Srf knockdown is further indicated.
doi:10.1371/journal.pgen.1001313.g007
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subsequent RNA isolation heart samples were directly snap frozen
in liquid nitrogen and stored at 280uC. For ChIP or histology
experiments heart samples were fixed with formaldehyde or
paraformaldehyde, respectively.
siRNA and Cell Transfection
For RNAi knockdown HL-1 cells were transfected with two
different siRNAs (Qiagen) per transcription factor (Table S12)
using two biological replicates each (4 replicates in total). As a
control, the cells were transfected with an unspecific siRNA
(siNon). Cells were grown to 70–80% confluence for at least two
days without addition of antibiotics. 36105 cells were seeded into
6-well plates with 2ml media resulting in 70–80% confluence after
4h. The mixture of 9ml (20mM) siRNA in 270ml of DMEM media
and 16ml Lipofectamine 2000 (Invitrogen) in 470ml DMEM media
was incubated for 20min at room temperature and added drop
wise to the cells. The cell culture media was changed after 24h and
cells were harvested for protein extraction or RNA preparation
after 48h. For reporter gene assays HEK293T cells were
transfected with Transfast (Promega) according to manufacturer’s
instruction.
mRNA Expression Analysis in Wild-Type and siRNA–
Treated Cells
Total RNA of cultured cells and heart tissues was isolated using
TRIzol reagent (Invitrogen) followed by DNase digest (Promega)
and ethanol precipitation according to standard protocols. Reverse
transcription reactions were carried out via AMV-RT (Promega)
with random hexamers (Amersham Pharmacia Biotech). Illumina
array analysis was performed by Integragen (France). For each set
of experiments two biological and two technical replicates were
analyzed using Illumina Mouse-6 v1.1 genome-wide microarrays.
To verify transcript expression levels of HL-1 cells and mouse
hearts, quantitative real-time PCR measurements were performed
using SYBR Green PCR Master Mix (ABgene) and the ABI
PRISM 7900HT Sequence Detection System. Gene expression
was calculated using the DCT method with normalization to the
housekeeping gene Hprt. Primer sequences and additional results
are given in Tables S8 and S13 and Figure S1.
Analysis of mRNA Expression Data in Wild-Type and
siRNA–Treated Cells
The raw and transformed data of the Illumina expression
microarrays (Mouse-6 v1.1 genome wide arrays) were deposited in
the ArrayExpress database at the EBI (accession code E-TABM-
376). Probe intensities were obtained from Integragen (France).
Probes were filtered according to the detection score given by the
Illumina array analysis software BeadStudio. Only probes with a
detection score greater or equal to 0.95 in at least one experiment
were retained. Probe intensities were qspline normalized and
probes assigned to one transcript (Ensembl v46, mm8) were
normalized using the median polish procedure. Differential
expression was determined using the limma package [65] of
Bioconductor 2.0 [66] and p-values were corrected for multiple
testing according to Benjamin and Yekutieli [67]. Only transcripts
with p-value smaller or equal to 0.05 in both siRNA-mediated
knockdowns when compared to siNon-treated cells were consid-
ered to be significantly differentially expressed.
MicroRNA Expression Analysis
Small RNAs were isolated from total RNA of HL-1 cells and
prepared for miRNA sequencing using Illumina Kit FG-102-1009
according to manufacturer’s protocol. For quantification of miR-
133a-1 in mouse hearts stem-loop qPCR (primer sequence:
GTTGGCTCTGGTGCAGGGTCCGAGGTATTCGCACCA-
GAGCCAACCAGCTG) and TaqMan qPCR (forward primer:
59ATTAATTTGGTC CCCTTCAAC, reverse primer:59GT-
GCAGGGTCCGAGGT, TaqMan probe 21 (Roche)) were
performed as described elsewhere [68,69].
MicroRNA-seq Data Analysis
Small RNAs were sequenced by Illumina/Solexa next-genera-
tion (single-end) sequencing technology. The small RNA-seq data
were deposited in the Gene Expression Omnibus (GEO) database
at the NCBI (accession code GSE26397). In two independent
siRNA-mediated knockdowns of Srf (Srf-si1 & Srf-si2) and an
unspecific siRNA we retrieved 14,911,499 (Srf-si1), 14,518,157
(Srf-si2) and 14,742,382 (siNon) unfiltered 36bp reads, which
yielded 5,634,650 (Srf-si1), 5,503,661 (Srf-si2) and 5,674,429
(siNon) unique (i.e. non-redundant) read sequences. These reads
were mapped to the mouse reference genome (NCBI v37, mm9)
using MicroRazerS [70] allowing at most 20 equally-best hits for
each read and using a seed length of 16 bases with at most one
mismatch. For Srf-si1 96.7%, for Srf-si2 96.2% and for siNon
96.5% of all unique sequences could be mapped to the mouse
genome. In total 402 miRNAs were identified, corresponding to
450 different loci. To annotate the aligned sequence reads with
miRNAs, we checked for overlaps with miRNA positions (http://
www.miRBase.org/, release 14.0). We tested for differential
expression between the Srf-si1/2 and siNon libraries using Fisher’s
exact test with FDR correction for multiple testing (p#0.05). For
all miRNAs identified as significantly differentially expressed in at
least one siRNA knockdown of Srf (but both either up- or
downregulated) compared to negative control we did target gene
predictions using the miRanda v3.0 algorithm [71]. Finally, the
target prediction revealed 192 of 429 differentially expressed
genes. Using a fisher exact test we found the number to be
statistical significant when compared to a prediction based on all
versus differentially expressed genes (p = 1.77e-5).
miRNA Expression Levels in HL-1 Cells Compared to
Human Right Ventricle
The number of unfiltered 36bp reads for wildtype HL-1 was
14,440,535, while the human heart samples produced 14,475,968
(NH-1, normal heart (NH)), 16,270,049 (NH-2), 12,940,172 (NH-
3) and 14,890,970 (NH-4) unfiltered reads, respectively, yielding
5,541,954 (HL-1), 5,176,852 (NH-1), 7,189,852 (NH-2), 3,397,365
(NH-3) and 5,075,129 (NH-4) unique reads. Mapping to mouse
and human reference genomes (mm9, NCBI v37 and hg18, NCBI
v36) was performed by MicroRazerS [70] allowing at most one
mismatch and 20 equally-best hits per read with a seed length of
16 (mouse) and 18 (human), respectively. 97% (HL-1) and 87–91%
(NH-1-4) of all unique sequences could be mapped to the
corresponding reference genome. In total 196 common, 107
mouse-specific and 180 human-specific miRNA families were
found (http://www.miRBase.org, release 14.0). To account for
cross-species differences in the specific-expression levels, we used
rank-transformed miRNA expression levels for comparison.
Chromatin Immunoprecipitation
ChIP experiments with HL-1 cells and mouse hearts were
carried out as previously described [72] with minor modifications.
The antibodies used are given in the Table S14. ChIP-chip
experiments of HL-1 cells were performed on NimbleGen custom
made microarrays with two biological duplicates (containing two
pooled technical replicates each). Samples were labeled and
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hybridized according to NimbleGen standard procedure. Sample
preparation for ChIP-seq of HL-1 cells was performed according
the Illumina library preparation procedure. Two pooled biological
replicates for Srf and H3ac were sequenced using Illumina/Solexa
next-generation (single-end) sequencing technology. ChIP-chip
and ChIP-seq data were confirmed by quantitative real-time PCR
using the SyberGreen I PCR Master Mix (Abgene) and the ABI
PRISM 7900HT Sequence Detection System or using the
RealTime ready DNA Probes Master with the Universal
ProbeLibrary and the LightCycler 1536 (Roche). Results of
ChIP-qPCR experiments are given in Figure S5 and primer
sequences for verifications in Table S13. ChIP after siRNA
knockdown of Srf in Hl-1 cells was performed using the LowCell
ChIP Protein A Kit from Diagenode according to the manufac-
ture’s instructions.
ChIP-chip Data Analysis
The raw and transformed data of the ChIP-chip experiments
and the array design were deposited in the ArrayExpress database
(accession code E-TABM-378 and A-MEXP-893). We designed a
set of two 385k NimbleGen arrays to represent enhancer and
promoter regions of 12,625 transcriptional start sites based on a
broad panel of muscle relevant data source (Table S1) [13]. The
arrays represented 89Mbp of the mouse genome build mm8 and
contained 740,000 probes with a tiling of 110bp (50–60bp gap
between probes). This included conserved regions (based on
PhastCons [31] score thresholds of 0.2) within 10kb upstream, the
full sequence within 2kb upstream and the first exon and intron of
the corresponding transcript.
The array intensities of each channel were normalized and log-
transformed using VSN [73]. Log-ratio enrichment levels for each
probe were calculated by subtraction of log Cy3 (Input) from log
Cy5 (ChIP sample). The signal of transcription factors were
smoothed by calculating a median over the probes inside a sliding
window of 600bp. To distinguish enriched probes a z-score and
empirical p-value for each probe on the null hypothesis that these
z-scores have a symmetric distribution with mean zero was
calculated. Significant probe positions (corrected for multiple
testing [74], FDR,0.1), with a distance less than 210bp were
combined into transcription factor binding sites. The histone
binding sites were identified as described previously [39].
ChIP-seq Data Analysis
The ChIP-seq data were deposited in the GEO database
(accession code GSE26397). Of the initial 6,967,318 and
8,364,328 sequence reads obtained in the Srf and H3ac ChIP-
seq experiment, respectively, 4,543,634 (65.2%) for Srf and
6,141,144 (73.4%) for H3ac could be mapped to the mouse
reference genome (NCBI v37, mm9) using the read mapping tool
RazerS [75]. Only uniquely mapped 36nt reads with at most two
mismatches were retained. To identify enriched regions we used
the CisGenome software [76]. For Srf we used a window size of
100bp, a step size of 25bp and a read count level of 10
(FDR=1.6%). For H3ac we applied a window size of 250bp, a
step size of 50bp and a read count level of 10 (FDR=4.7%). After
peak localization the found Srf and H3ac peaks were filtered (see
Text S1) identifying 2,190 Srf and 10,486 H3ac ChIP-seq peaks.
TFBS Conservation Analysis
The occurrence of transcription factor binding motifs within
observed peaks was analyzed with TRANSFAC MATCH
program [45] by using 6250bp sequence surrounding the peak
center and position weight matrices corresponding to the studied
factors obtained from TRANSFAC [29]. The TRANSFAC
matrices used for motif search are listed in Table S7. Presence
of the CArG-box was determined by searching the pattern CC(A/
T)6GG with two errors at most. The degree of conservation of
respective motifs was studied using PhastCons conserved elements
[31]. In addition 100% conservation between human and mouse
was defined using 100bp windows.
Occurrence and Co-Occurrence of TFBS
Identified ChIP-chip or ChIP-seq binding sites were assigned to
transcriptional start sites if located within 10kb upstream or in the
transcribed region. General co-regulation of a gene by two or
more transcription factors was defined irrespective of the distance
between the binding sites. In addition, co-occurrence between
transcription factors or histone modifications was defined if the
centers of the peaks had a distance below 6500bp.
Gene Ontology Associations to Gene Groups
The association of gene groups to Gene Ontology (GO) terms
[77] was assessed as described previously [78] (conditional
hypergeometric test, p,0.001). To analyze the association of
differentially expressed transcripts with GO categories, transcripts
were mapped to genes. Overrepresentation was tested against all
genes represented on the ChIP and siRNA array, respectively.
Data Analysis
Standard bioinformatic analysis was carried out using R and
Bioconductor packages [66] as well as Perl and its BioPerl
modules. If not mentioned otherwise, p-values given are based on
Student’s t-test.
Protein Extraction and Western Blot
Specific or non-specific siRNA treated HL-1 cardiomyocytes
were used for Western Blot analysis to monitor the knockdown
efficiency at protein level. HL-1 cells were treated with lysis buffer
(20mM Tris-HCl pH 7.4, 150nM NaCl, 1mM EDTA, 1% Triton,
1mM DTT, 0.1mM PMSF, 16Protease Inhibitor Cocktail, 1mM
NaVO4) for protein extraction. Western Blot was performed
according to standard protocols. All antibodies with their
respective dilution are given in Table S14.
Reporter Gene Assays and Site-Directed Mutagenesis
Reporter constructs were made by cloning the 385bp long
human DPF3 minimal promoter (chr14:72.430.563–72.430.943,
NCBI36/hg18) and the 485bp long regulatory region downstream
of mmu-miR-125b-1 (chr9:41.390.238–41.390.700, NCBI37/
mm9) into the pGL3 basic vector (Promega). Transient co-
transfections were carried out in triplicates in 96-well plates in
HEK293T cells by transfecting 50ng of reporter vector, 5ng of
Firefly luciferase vector for internal normalization of transfection
efficiency and 50–150ng of the respective expression vectors.
Activity was measured by Dual-Luciferase assay (Promega) after
48 hours. Site-directed mutagenesis of DNA was carried out using
the QuikChange site-directed mutagenesis kit (Stratagene) accord-
ing to manufacturer’s instructions. Oligonucleotides for mutagen-
esis were designed to introduce deletions or mutations of the
potential Nkx2.5 or Srf binding sites. Mutagenesis was confirmed
by plasmid sequencing carried out at MWG Biotech.
Immunocytochemistry
For immunofluorescence analyses, the heart tissues were fixed
over night with 4% paraformaldehyde, dehydrated and embedded
in paraffin. Subsequently sections of 8mm were de-paraffinized,
rehydrated and antigen retrieval was performed in 10mM citric
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acid buffer (pH 6). Blocking was carried out in 5% normal goat
serum in PBS for 1h at room temperature. Primary and secondary
antibodies were applied in the same buffer for 2h at room
temperature, each followed by three washes in PBS and a DAPI
counterstaining. Antibodies with their respective dilution are listed
in Table S14. The sections were mounted in Flouromount G
(Electron Microscopy Science) and examined on a Zeiss LSM 510
META confocal microscope (Carl Zeiss).
Supporting Information
Figure S1 RNAi induced knockdown of Gata4, Mef2a, Nkx2.5
and Srf. Knockdown efficiency of two different siRNAs per
transcription factor in HL-1 cells was analyzed on protein level by
(A) Western Blot and (B) quantitative real-time PCR 48h after
transfection. Histone 3 served as loading control. mRNA
expression levels are normalized to Hprt and relative to unspecific
siRNA.
Found at: doi:10.1371/journal.pgen.1001313.s001 (0.12 MB TIF)
Figure S2 Influence of RNAi knockdown of Srf, Gata4, Mef2a
and Nkx2.5 on cell death 48h after transfection. (A) Cell viability
study. (B) Annexin apoptosis assay.
Found at: doi:10.1371/journal.pgen.1001313.s002 (0.12 MB TIF)
Figure S3 Co-occurrence of transcription factor binding sites
with histone modifications. Transcription factor binding sites of
Gata4, Mef2a, Nkx2.5 and Srf co-occur in ,80% with one or
more histone marks. The overlap of the transcription factor
binding events and the respective histone modification H3ac,
H3K4me2, H3K4me3 and H4ac is 55% on average. The
expected percentage overlap would be 23–38% based on 100times
random distribution of transcription factor binding sites on
genomic sequences.
Found at: doi:10.1371/journal.pgen.1001313.s003 (0.06 MB TIF)
Figure S4 The activating potential of Srf in relation to
accompanying histone modifications. Srf binding sites were
classified into five classes: ‘Srf only’ (only binding of Srf, no
histone modification is observed), H3ac, H3K4me2, H3K4me3
and H4ac (histone modification in addition to Srf binding).
Boxplots representing the distribution of expression levels of
transcripts assigned to these binding sites are shown. The number
of transcripts belonging to each group are indicates in brackets
below the group name. A single transcript can belong to multiple
groups if it has multiple histone modifications. Estimated
coefficients for the influence of individual histone modifications
on target gene expression and their associated p-values are derived
by a linear model using least square estimation and F statistics.
The ‘Srf only’ group was taken as reference.
Found at: doi:10.1371/journal.pgen.1001313.s004 (0.09 MB TIF)
Figure S5 ChIP-chip confirmation by qPCR. Known and novel
binding sites of Gata4 (A), Mef2a (B), Nkx2.5 (C) and Srf (D) were
confirmed by quantitative real-time PCR.
Found at: doi:10.1371/journal.pgen.1001313.s005 (0.08 MB TIF)
Table S1 Source considered for array design.
Found at: doi:10.1371/journal.pgen.1001313.s006 (0.23 MB PDF)
Table S2 ChIP-chip confirmation by literature. Conformation
of 42 genes, which were previously described to be directly or
indirectly regulated by Gata4, Mef2a, Nkx2.5 or Srf as pointed out
in the given publication.
Found at: doi:10.1371/journal.pgen.1001313.s007 (0.29 MB PDF)
Table S3 GO term analysis of genes bound by Gata4. Statistical
analysis of overrepresented ‘Biological process’ GO term associ-
ation of genes regulated by Gata4 in HL-1 cells according to
ChIP-chip data.
Found at: doi:10.1371/journal.pgen.1001313.s008 (0.24 MB PDF)
Table S4 GO term analysis of genes bound by Mef2a. Statistical
analysis of overrepresented ‘Biological process’ GO term associ-
ation of genes regulated by Mef2a in HL-1 cells according to
ChIP-chip data.
Found at: doi:10.1371/journal.pgen.1001313.s009 (0.24 MB PDF)
Table S5 GO term analysis of genes bound by Nkx2.5.
Statistical analysis of overrepresented ‘Biological process’ GO
term association of genes regulated by Nkx2.5 in HL-1 cells
according to ChIP-chip data.
Found at: doi:10.1371/journal.pgen.1001313.s010 (0.23 MB PDF)
Table S6 GO term analysis of genes bound by Srf. Statistical
analysis of overrepresented ‘Biological process’ GO term associ-
ation of genes regulated by Srf in HL-1 cells according to ChIP-
chip data.
Found at: doi:10.1371/journal.pgen.1001313.s011 (0.24 MB PDF)
Table S7 TRANSFAC identifier. Transcription factor binding
matrices which were used for motif search.
Found at: doi:10.1371/journal.pgen.1001313.s012 (0.23 MB PDF)
Table S8 Genes deregulated in RNAi knockdown of Gata4,
Mef2a, Nkx2.5 and Srf. Deregulation of gene expression for a
subset of genes was determined using quantitative real-time PCR.
Fold changes are calculated in relation to unspecific siRNA treated
cells.
Found at: doi:10.1371/journal.pgen.1001313.s013 (0.27 MB PDF)
Table S9 MiRNAs with Srf binding events. ChIP-seq analysis
reveals 22 miRNAs with at least one Srf binding event within a
genomic region of 610kb. Srf-ChIP peaks and miRNA positions
based on mouse genome NCBIv37 (mm9).
Found at: doi:10.1371/journal.pgen.1001313.s014 (0.23 MB PDF)
Table S10 Significantly deregulated miRNAs in Srf knockdown.
42 miRNAs (49 loci) were differentially expressed in Srf
knockdown compared to control miRNA loci based on mouse
genome NCBIv37 (mm9). Matched reads to mature and star
miRNA sequence based on miRBase annotations (release 14.0).
Found at: doi:10.1371/journal.pgen.1001313.s015 (0.32 MB PDF)
Table S11 Predicted miRNA targets (corresponding to
Figure 5C). Igfbp5, Nfic and Ctnnal1 represent up-regulated
genes with predicted miRNA target sites of down regulated
miRNAs in Srf knockdown.
Found at: doi:10.1371/journal.pgen.1001313.s016 (0.24 MB PDF)
Table S12 siRNAs sequences. Sequences of siRNAs used in
RNAi experiments of Gata4, Mef2a, Nkx2.5 and Srf in HL-1 cells.
Found at: doi:10.1371/journal.pgen.1001313.s017 (0.23 MB PDF)
Table S13 Oligonucleotide sequences. Primer sequences used
for qPCR expression measurements and ChIP-chip verification
and TaqMan Assays used for ChIP-qPCR measurements are
listed.
Found at: doi:10.1371/journal.pgen.1001313.s018 (0.28 MB PDF)
Table S14 Antibodies. Antibodies used in ChIP, Immunocyto-
chemistry and Western Blot and their respective amount used in
the experiments are given.
Found at: doi:10.1371/journal.pgen.1001313.s019 (0.24 MB PDF)
Table S15 Gata4, Mef2a, Nkx2.5, and Srf enriched ChIP-chip
peaks according to empirical distribution of lowly enriched probes
(FDR,0.1). Peak loci are based on mouse genome NCBIv36
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(mm8). Peaks were subsequently assigned to genes if they lay less
than 10 kb upstream or inside a gene (Ensembl v45).
Found at: doi:10.1371/journal.pgen.1001313.s020 (0.41 MB
XLS)
Table S16 Srf and H3ac enriched ChIP-seq peaks according to
CisGenome software. Sequence reads were mapped to mouse
genome NCBIv37 (mm9) using RazerS. Peaks were subsequently
assigned to genes if they lay less than 10 kb upstream or inside a
gene (Ensembl v54).
Found at: doi:10.1371/journal.pgen.1001313.s021 (1.62 MB
XLS)
Table S17 Gata4, Mef2a, Nkx2.5, and Srf differentially
expressed genes (Ensembl v45) using duplicates of two different
siRNAs.
Found at: doi:10.1371/journal.pgen.1001313.s022 (0.21 MB
XLS)
Table S18 List of miRNAs and target genes of differentially
expressed miRNAs in HL-1 cells treated with Srf siRNAs. MiRNA
loci based on mouse genome NCBIv37 (mm9). Matched reads to
mature and star miRNA sequence based on miRBase annotations
(release 14.0). For all miRNAs (in total 77) identified as
significantly differentially expressed in at least one siRNA
knockdown of Srf (Srf-si1/Srf-si2, but both either up- or
downregulated) compared to negative control target gene
predictions using the miRanda v3.0 algorithm were performed.
For prediction the mature miRNA sequences and the 39UTR
sequences from all differentially expressed genes were used.
Found at: doi:10.1371/journal.pgen.1001313.s023 (0.10 MB
XLS)
Text S1 Additional supporting Materials and Methods.
Found at: doi:10.1371/journal.pgen.1001313.s024 (0.31 MB PDF)
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